• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺动脉高压诱导的右心室衰竭时体内线粒体氧合增加:线粒体抑制是心力衰竭的驱动因素吗?

Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?

作者信息

Balestra Gianmarco M, Mik Egbert G, Eerbeek Otto, Specht Patricia A C, van der Laarse Willem J, Zuurbier Coert J

机构信息

Department of Anesthesiology, Laboratory of Experimental Anesthesiology, Erasmus MC- University Medical Center Rotterdam, Rotterdam, The Netherlands.

Department of Anatomy, Embryology and Physiology, AMC, Amsterdam, The Netherlands.

出版信息

Respir Res. 2015 Feb 3;16(1):6. doi: 10.1186/s12931-015-0178-6.

DOI:10.1186/s12931-015-0178-6
PMID:25645252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4320611/
Abstract

BACKGROUND

The leading cause of mortality due to pulmonary arterial hypertension (PAH) is failure of the cardiac right ventricle. It has long been hypothesized that during the development of chronic cardiac failure the heart becomes energy deprived, possibly due to shortage of oxygen at the level of cardiomyocyte mitochondria. However, direct evaluation of oxygen tension levels within the in vivo right ventricle during PAH is currently lacking. Here we directly evaluated this hypothesis by using a recently reported technique of oxygen-dependent quenching of delayed fluorescence of mitochondrial protoprophyrin IX, to determine the distribution of mitochondrial oxygen tension (mitoPO2) within the right ventricle (RV) subjected to progressive PAH.

METHODS

PAH was induced through a single injection of monocrotaline (MCT). Control (saline-injected), compensated RV hypertrophy (30 mg/kg MCT; MCT30), and RV failure (60 mg/kg MCT; MCT60) rats were compared 4 wk after treatment. The distribution of mitoPO2 within the RV was determined in mechanically-ventilated, anaesthetized animals, applying different inspired oxygen (FiO2) levels and two increment dosages of dobutamine.

RESULTS

MCT60 resulted in RV failure (increased mortality, weight loss, increased lung weight), MCT30 resulted in compensated RV hypertrophy. At 30% or 40% FiO2, necessary to obtain physiological arterial PO2 in the diseased animals, RV failure rats had significantly less mitochondria (15% of total mitochondria) in the 0-20 mmHg mitoPO2 range than hypertrophied RV rats (48%) or control rats (54%). Only when oxygen supply was reduced to 21% FiO2, resulting in low arterial PO2 for the MCT60 animals, or when oxygen demand increased with high dose dobutamine, the number of failing RV mitochondria with low oxygen became similar to control RV. In addition, metabolic enzyme analysis revealed similar mitochondrial mass, increased glycolytic hexokinase activity following MCT, with increased lactate dehydrogenase activity only in compensated hypertrophied RV.

CONCLUSIONS

Our novel observation of increased mitochondrial oxygenation suggests down-regulation of in vivo mitochondrial oxygen consumption, in the absence of hypoxia, with transition towards right ventricular failure induced by pulmonary arterial hypertension.

摘要

背景

肺动脉高压(PAH)导致死亡的主要原因是右心室衰竭。长期以来,人们一直推测,在慢性心力衰竭发展过程中,心脏可能因心肌细胞线粒体水平的氧气短缺而出现能量供应不足。然而,目前缺乏对PAH期间体内右心室内氧张力水平的直接评估。在此,我们通过使用最近报道的一种依赖氧气淬灭线粒体原卟啉IX延迟荧光的技术,直接评估这一假设,以确定在进行性PAH的右心室(RV)内线粒体氧张力(mitoPO2)的分布。

方法

通过单次注射野百合碱(MCT)诱导PAH。在治疗4周后,比较对照组(注射生理盐水)、代偿性右心室肥厚组(30mg/kg MCT;MCT30)和右心室衰竭组(60mg/kg MCT;MCT60)大鼠。在机械通气、麻醉的动物中,应用不同的吸入氧(FiO2)水平和两种递增剂量的多巴酚丁胺,测定右心室内mitoPO2的分布。

结果

MCT60导致右心室衰竭(死亡率增加、体重减轻、肺重量增加),MCT30导致代偿性右心室肥厚。在患病动物中,为获得生理动脉血氧分压所需的30%或40% FiO2条件下,右心室衰竭大鼠在0 - 20 mmHg mitoPO2范围内的线粒体显著少于肥厚性右心室大鼠(48%)或对照大鼠(54%)。只有当氧气供应降至21% FiO2,导致MCT60动物的动脉血氧分压较低时,或者当高剂量多巴酚丁胺增加氧气需求时,低氧的衰竭右心室线粒体数量才与对照右心室相似。此外,代谢酶分析显示线粒体质量相似,MCT后糖酵解己糖激酶活性增加,仅在代偿性肥厚的右心室中乳酸脱氢酶活性增加。

结论

我们对线粒体氧合增加的新观察表明,在无缺氧情况下,随着肺动脉高压诱导的右心室衰竭的转变,体内线粒体氧消耗下调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84d/4320611/f6e9d4a00bad/12931_2015_178_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84d/4320611/87c8b8b3945c/12931_2015_178_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84d/4320611/310a586be115/12931_2015_178_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84d/4320611/97a90054b399/12931_2015_178_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84d/4320611/cd302eba8c96/12931_2015_178_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84d/4320611/f6e9d4a00bad/12931_2015_178_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84d/4320611/87c8b8b3945c/12931_2015_178_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84d/4320611/310a586be115/12931_2015_178_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84d/4320611/97a90054b399/12931_2015_178_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84d/4320611/cd302eba8c96/12931_2015_178_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e84d/4320611/f6e9d4a00bad/12931_2015_178_Fig5_HTML.jpg

相似文献

1
Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?肺动脉高压诱导的右心室衰竭时体内线粒体氧合增加:线粒体抑制是心力衰竭的驱动因素吗?
Respir Res. 2015 Feb 3;16(1):6. doi: 10.1186/s12931-015-0178-6.
2
Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.尿皮质素 2 可改善右心功能并减轻肺动脉高压。
Cardiovasc Res. 2018 Jul 1;114(8):1165-1177. doi: 10.1093/cvr/cvy076.
3
Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.费希尔大鼠在严重肺动脉高压时表现出适应性不良的结构和分子右心室重构:一种易患右心衰竭的遗传性模型。
Cardiovasc Res. 2019 Mar 15;115(4):788-799. doi: 10.1093/cvr/cvy258.
4
Energy Metabolism in the Failing Right Ventricle: Limitations of Oxygen Delivery and the Creatine Kinase System.右心衰竭时的能量代谢:氧输送的局限性和肌酸激酶系统。
Int J Mol Sci. 2019 Apr 12;20(8):1805. doi: 10.3390/ijms20081805.
5
Distinct right ventricle remodeling in response to pressure overload in the rat.大鼠压力超负荷致右心室重构的特征。
Am J Physiol Heart Circ Physiol. 2016 Jul 1;311(1):H85-95. doi: 10.1152/ajpheart.00089.2016. Epub 2016 May 6.
6
Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.甘草酸,一种高迁移率族蛋白B1的抑制剂,可减轻大鼠野百合碱诱导的肺动脉高压和血管重塑。
Respir Res. 2014 Nov 25;15:148. doi: 10.1186/s12931-014-0148-4.
7
Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.同种异体干细胞疗法通过改善肺动脉高压大鼠的肺部病理状况来改善右心室功能。
Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1606-16. doi: 10.1152/ajpheart.00590.2009. Epub 2009 Sep 25.
8
Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate.野百合碱诱导的肺动脉高压大鼠右心室心肌氧张力降低,并被肌醇三磷酸恢复。
Sci Rep. 2021 Sep 9;11(1):18002. doi: 10.1038/s41598-021-97470-6.
9
Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.通过给予野百合碱建立大鼠肺动脉高压模型。
Methods Mol Biol. 2018;1816:233-241. doi: 10.1007/978-1-4939-8597-5_18.
10
Sulforaphane Improves Redox Homeostasis and Right Ventricular Contractility in a Model of Pulmonary Hypertension.莱菔硫烷可改善肺动脉高压模型中的氧化还原平衡和右心室收缩功能。
J Cardiovasc Pharmacol. 2024 Jun 1;83(6):612-620. doi: 10.1097/FJC.0000000000001557.

引用本文的文献

1
SUL-150 Limits Vascular Remodeling and Ventricular Failure in Pulmonary Arterial Hypertension.SUL-150可限制肺动脉高压中的血管重塑和心室衰竭。
Int J Mol Sci. 2025 Jul 25;26(15):7181. doi: 10.3390/ijms26157181.
2
Dysregulation of Mitochondrial in Pulmonary Hypertension-Related Right Ventricular Remodeling: Pathophysiological Features and Targeting Drugs.肺动脉高压相关右心室重构中线粒体的失调:病理生理特征与靶向药物
Rev Cardiovasc Med. 2025 Mar 18;26(3):25781. doi: 10.31083/RCM25781. eCollection 2025 Mar.
3
The role of lactate metabolism and lactylation in pulmonary arterial hypertension.

本文引用的文献

1
Up-regulation of hexokinase1 in the right ventricle of monocrotaline induced pulmonary hypertension.野百合碱诱导的肺动脉高压大鼠右心室中己糖激酶1的上调
Respir Res. 2014 Oct 8;15(1):119. doi: 10.1186/s12931-014-0119-9.
2
HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.缺氧诱导因子 1 通过靶向线粒体通透性转换孔减少心脏的缺血再灌注损伤。
Cardiovasc Res. 2014 Oct 1;104(1):24-36. doi: 10.1093/cvr/cvu172. Epub 2014 Jul 25.
3
Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.
乳酸代谢和乳酸化在肺动脉高压中的作用。
Respir Res. 2025 Mar 12;26(1):99. doi: 10.1186/s12931-025-03163-3.
4
Low-frequency ultrasound for pulmonary hypertension therapy.用于肺动脉高压治疗的低频超声
Respir Res. 2024 Feb 5;25(1):70. doi: 10.1186/s12931-024-02713-5.
5
Mitochondrial Integrity Is Critical in Right Heart Failure Development.线粒体完整性对于右心衰竭的发展至关重要。
Int J Mol Sci. 2023 Jul 5;24(13):11108. doi: 10.3390/ijms241311108.
6
Reversal of Right Ventricular Hypertrophy and Dysfunction by Prostacyclin in a Rat Model of Severe Pulmonary Arterial Hypertension.前列环素逆转肺动脉高压大鼠右心室肥厚和功能障碍。
Int J Mol Sci. 2022 May 12;23(10):5426. doi: 10.3390/ijms23105426.
7
Direct cardiac effects of SGLT2 inhibitors.钠-葡萄糖协同转运蛋白 2 抑制剂的心脏直接作用。
Cardiovasc Diabetol. 2022 Mar 18;21(1):45. doi: 10.1186/s12933-022-01480-1.
8
Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate.野百合碱诱导的肺动脉高压大鼠右心室心肌氧张力降低,并被肌醇三磷酸恢复。
Sci Rep. 2021 Sep 9;11(1):18002. doi: 10.1038/s41598-021-97470-6.
9
Preventive training does not interfere with mRNA-encoding myosin and collagen expression during pulmonary arterial hypertension.预防性训练不会干扰肺动脉高压期间肌球蛋白和胶原的 mRNA 编码表达。
PLoS One. 2021 Sep 8;16(9):e0244768. doi: 10.1371/journal.pone.0244768. eCollection 2021.
10
Mitochondrial Oxygen Monitoring During Surgical Repair of Congenital Diaphragmatic Hernia or Esophageal Atresia: A Feasibility Study.先天性膈疝或食管闭锁手术修复期间的线粒体氧监测:一项可行性研究。
Front Pediatr. 2020 Sep 2;8:532. doi: 10.3389/fped.2020.00532. eCollection 2020.
右心对肺动脉高压的适应:生理学和病理生物学。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D22-33. doi: 10.1016/j.jacc.2013.10.027.
4
Regulation of cellular metabolism: programming and maintaining metabolic homeostasis.细胞代谢的调控:编程与维持代谢稳态
J Appl Physiol (1985). 2013 Dec;115(11):1583-8. doi: 10.1152/japplphysiol.00894.2013. Epub 2013 Oct 10.
5
Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart.将己糖激酶II靶向线粒体以调节能量代谢并减轻心脏缺血再灌注损伤。
Br J Pharmacol. 2014 Apr;171(8):2067-79. doi: 10.1111/bph.12363.
6
A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension.右心室肥厚中的代谢重塑与血管生成减少以及肺动脉高压从代偿状态向失代偿状态的转变有关。
J Mol Med (Berl). 2013 Nov;91(11):1315-27. doi: 10.1007/s00109-013-1059-4. Epub 2013 Jul 12.
7
Cutaneous respirometry by dynamic measurement of mitochondrial oxygen tension for monitoring mitochondrial function in vivo.通过动态测量线粒体氧张力进行皮肤呼吸测量,以监测体内线粒体功能。
Mitochondrion. 2013 Sep;13(5):507-14. doi: 10.1016/j.mito.2012.10.005. Epub 2012 Oct 12.
8
Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.右心室肥厚中脂肪酸氧化的治疗性抑制:利用兰德尔循环。
J Mol Med (Berl). 2012 Jan;90(1):31-43. doi: 10.1007/s00109-011-0804-9. Epub 2011 Aug 28.
9
Molecular signature of a right heart failure program in chronic severe pulmonary hypertension.慢性重度肺动脉高压右心衰竭方案的分子特征。
Am J Respir Cell Mol Biol. 2011 Dec;45(6):1239-47. doi: 10.1165/rcmb.2010-0412OC. Epub 2011 Jun 30.
10
Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure.右心室肥厚和衰竭中的线粒体代谢适应。
J Mol Med (Berl). 2010 Oct;88(10):1011-20. doi: 10.1007/s00109-010-0679-1. Epub 2010 Sep 4.